Efficacy of Cefiderocol Against Endophthalmitis Isolates

Area of Science:

• Ophthalmology
• Infectious Diseases
• Pharmacology

Background:

• Endophthalmitis is a severe intraocular infection risking blindness.
• Rising multi-drug-resistant organisms challenge current antibiotic treatments.
• Cefiderocol is a novel antibiotic effective against resistant Gram-negative bacteria.

Purpose of the Study:

• To evaluate cefiderocol's efficacy against endophthalmitis pathogens.
• To compare cefiderocol with standard antibiotics like ceftazidime and amikacin.
• To assess potential interactions between cefiderocol and vancomycin.

Main Methods:

• Epsilometer testing was used to determine Minimum Inhibitory Concentrations (MICs).
• Bacterial isolates from endophthalmitis cases were tested.
• Synergistic and antagonistic effects of cefiderocol and vancomycin were evaluated.

Main Results:

• Cefiderocol demonstrated lower MICs than ceftazidime for key Gram-negative species.
• No antagonistic effects were observed between cefiderocol and vancomycin.
• Cefiderocol shows potential against resistant Gram-negative endophthalmitis strains.

Conclusions:

• Cefiderocol is a potential therapeutic option for multi-drug-resistant Gram-negative bacterial endophthalmitis.
• This study is the first to investigate cefiderocol in endophthalmitis strains.
• Further research into cefiderocol's intraocular safety profile is warranted.